Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

85.79
Delayed Data
As of 4:14pm ET
 -0.76 / -0.88%
Today’s Change
71.46
Today|||52-Week Range
103.73
+16.45%
Year-to-Date
How High Can Corbus Pharmaceuticals Stock Go?
4:50pm / MotleyFool.com - Paid Partner Content
Biotech ETFs Powered by Q4 Earnings
Feb 10 / Zacks.com - Paid Partner Content
Sector Gamma As Buys Vertex Pharmaceuticals, Shire PLC, United Therapeutics, Sells Bi...
Feb 15 / GuruFocus News - Paid Partner Content
Why Vertex Pharmaceuticals Stock Surged Higher in January
Feb 09 / MotleyFool.com - Paid Partner Content
Zacks.com featured highlights: Ets, Incyte, Abercrombie & Fitch, Vertex Pharmaceutica...
Feb 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close86.55
Today’s open86.55
Day’s range85.72 - 87.33
Volume1,263,166
Average volume (3 months)1,968,270
Market cap$21.5B
Dividend yield--
Data as of 4:14pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+80.09%
Earnings growth (this year)+89.35%
Earnings growth (next 5 years)+68.90%
Revenue growth (last year)+64.89%
P/E ratioNM
Price/Sales10.59
Price/Book16.06

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.30-0.71%
INCYIncyte Corp-1.00-0.82%
ZTSZoetis Inc-0.09-0.17%
BAXBaxter International...+0.10+0.20%
Data as of 4:02pm ET, 02/22/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.30
Annual revenue (last year)$1.7B
Annual profit (last year)-$112.1M
Net profit margin-6.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
EVP, Chief Operating &
Financial Officer
Ian F. Smith
Corporate headquarters
Boston, Massachusetts

Forecasts


Search for Jobs